Cart
sales@molnova.com
NSC-109555 ditosylate
CAS No. 66748-43-4
NSC-109555 ditosylate( DDUG | NSC109555 | NSC 109555 )
Catalog No. M15549 CAS No. 66748-43-4
A potent, selective, reversible, ATP-competitive Chk2 inhibitor with IC50 of 0.2 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNSC-109555 ditosylate
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective, reversible, ATP-competitive Chk2 inhibitor with IC50 of 0.2 uM.
-
DescriptionA potent, selective, reversible, ATP-competitive Chk2 inhibitor with IC50 of 0.2 uM; displays no effect on a range of other kinases including Chk1 (IC50>10 uM); inhibits histone H1 phosphorylation (IC50=0.24 uM) and attenuates mitochondrial ATP synthesis; exhibits antiproliferative activity in a number of leukemias in vivo.
-
In Vitro——
-
In Vivo——
-
SynonymsDDUG | NSC109555 | NSC 109555
-
PathwayAngiogenesis
-
TargetChk
-
RecptorChk
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number66748-43-4
-
Formula Weight752.86
-
Molecular FormulaC19H24N10O.2C7H8O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC1=CC=C(/C(C)=N/N=C(N)/N)C=C1)NC2=CC=C(/C(C)=N/N=C(N)/N)C=C2.OS(=O)(C3=CC=C(C)C=C3)=O.OS(=O)(C4=CC=C(C)C=C4)=O
-
Chemical Name4,4'-diacetyldiphenylurea bis(guanylhydrazone) ditosylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
SAR-020106
SAR-020106 is a potent, ATP-competitive, and selective CHK1 inhibitor with an IC50 of 13.3 nmol/L on the isolated human enzyme.SAR-020106 is an ATP-competitive, potent, and selective CHK1 inhibitor with an IC(50) of 13.3 nmol/L on the isolated human enzyme. This compound abrogates an etoposide-induced G(2) arrest with an IC(50) of 55 nmol/L in HT29 cells, and significantly enhances the cell killing of gemcitabine and SN38 by 3.0- to 29-fold in several colon tumor lines in vitro and in a p53-dependent fashion.
-
PHI-101
PHI-101 is an orally available and selective checkpoint kinase 2 (Chk2) inhibitor for the study of refractory acute myelogenous leukemia (AML) and ovarian cancer.
-
LY2603618
A potent and selective small molecule inhibitor of Chk1 (IC50=?7 nM); promotes impaired DNA synthesis and elevates H2A.X phosphorylation indicative of DNA damage and premature entry into mitosis.
